Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 4, 2002, Pages 413-418

  Greiff, Lennart ^a   Persson, Carl G A ^a   Andersson, Morgan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA 2 MACROGLOBULIN; ANTIHISTAMINIC AGENT; DESLORATADINE; FUCOSE;

ADULT; ALLERGIC RHINITIS; ARTICLE; BRONCHUS SECRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036825269     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62044-3     Document Type: Article

References (20)

1. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gillman A, Goodman G, Rall T, Murad F, editors: The Pharmacologic Basis of Therapeutics. 7th ed. New York: MacMillan, 1987:605-638.
2. 1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990;142:167-171.
3. 2-macroglobulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995;96: 97-103.
4. Persson CG, Erjefält JS, Greiff L, et al. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998;11:958-970.
5. Rogers DF. Airway goblet cells: responsive and adaptable front-line-defenders. Eur Respir J 1994;7:1690-1706.
6. Raphael GD, Druce HM, Baraniuk JN, Kaliner MA. The pathophysiology of rhinitis I. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis 1988;138:413-420.
7. Jeffery PK, Li D. Airway mucosa: secretory cells, mucus and mucin genes. Eur Respir J 1997;10:1655-1662.
8. Freney M, Irth H, Lindberg H, et al. Fast screening of fucose in airway secretions by parallel ligand-exchange chromatography in combination with post-column derivatisation and fluorescence detection. Chromatographia 2001;54:439-445.
9. Yuta A, Ali M, Sabol M, et al. Mucoglycoprotein hypersecretion in allergic rhinitis and cystic fibrosis. Am J Physiol 1997; 273:L1203-L1207.
10. Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucus hypersecretion. Am J Physiol 1998;274: L1017-L1023.
11. Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: a comparative review. Drugs 1999;57:31-47.
12. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
13. Svensson C, Baumgarten CR, Pipkorn U, et al. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax 1989;44:13-18.
14. Svensson C, Pipkorn U, Alkner U, et al. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992;22:411-416.
15. Mariassy AT, Plopper CG, St. George JA, Wilson DW. Tracheobronchial epithelium of the sheep: IV. Lectin histochemical characterization of secretory epithelial cells. Anat Res 1988; 222:49-59.
16. Castells MT, Ballesta J, Madrid JF, et al. Characterization of glycoconjugates in developing rat respiratory system by means of conventional and lectin immunochemistry. Histochemistry 1991;95:419-426.
17. Lopez-Vidriero M. Individual and group correlations of sputum viscosity and airways obstruction. Bull Physiopathol Respir 1973;9:339-347.
18. Keal EE, Reid L. Pathologic alterations in mucus in asthma within and without the cell. In: Stein M, editor. New Directions in Asthma. Park Ridge, IL: American College of Chest Physicians, 1975:223-239.
19. Storaas T, Andersson M, Persson CG, et al. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa. in vivo. Laryngoscope 2000;110:1543-1547.
20. Andersson M, Svensson C, Persson CG, et al. Dose-dependent effects of budesonide aqueous nasal spray on symptoms of allergic rhinitis in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol 2000;85:279-283.